Annick Sawala

Company: Vivan Therapeutics

Job title: Head of Translational Research

Seminars:

From Precision Medicine to Personalised Medicine in Oncology: Predicting Effective Treatments Based on Complex Tumour Gene Signatures Using a Novel In Vivo Screening Technology 3:50 pm

Genetic complexity: Tumours are driven by a network of oncogenic genetic alterations and tumour signatures are incredibly diverse across patient population Drosophila avatars: a rapid and cost-effective generation of in vivo models with genetically engineered complex tumour signatures for large-scale drug screening Utilising whole-exome sequencing and in vivo drug screening to uncover actionable insights into…Read more

day: Day 2 PM